- Home
- DHT vs HTFL Comparison
DHT vs HTFL Comparison
Compare DHT & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DHT | HTFL |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | Bermuda | United States |
| Employees | N/A | 843 |
| Industry | Marine Transportation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | DHT | HTFL |
|---|---|---|
| Price | $17.57 | $28.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $19.33 | ★ $38.20 |
| AVG Volume (30 Days) | ★ 2.8M | 945.7K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | ★ 5.36% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.85 | $27.66 |
| Revenue Next Year | N/A | $23.55 |
| P/E Ratio | $12.73 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.61 | $20.13 |
| 52 Week High | $20.55 | $41.22 |
Technical Indicators
Market Signals| Indicator | DHT | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 41.15 | 46.70 |
| Support Level | $16.98 | $25.56 |
| Resistance Level | $18.80 | $28.98 |
| Average True Range (ATR) | 0.62 | 1.71 |
| MACD | -0.14 | -0.18 |
| Stochastic Oscillator | 7.55 | 20.68 |
Price Performance
Historical ComparisonAbout DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. The company's primary business is operating a fleet of crude oil tankers, with a secondary activity of providing technical management services. Its fleet trades internationally and consists of VLCC crude oil tankers. The group generates revenues from time charter and spot market operations. It operates vessels through its subsidiary management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from Voyage charter revenues.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.